milrinone has been researched along with Cerebrovascular Disorders in 3 studies
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thunderclap headache is the most common clinical manifestation; however, other symptoms can result from complications of the disease, such as stroke, brain edema, and seizures." | 5.62 | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion. ( Aldandan, HW; Alrayes, MM; Alshagawi, ZA; Alzahrani, SK; Hadhiah, KM, 2021) |
| "Thunderclap headache is the most common clinical manifestation; however, other symptoms can result from complications of the disease, such as stroke, brain edema, and seizures." | 1.62 | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion. ( Aldandan, HW; Alrayes, MM; Alshagawi, ZA; Alzahrani, SK; Hadhiah, KM, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadhiah, KM | 1 |
| Alshagawi, ZA | 1 |
| Alzahrani, SK | 1 |
| Alrayes, MM | 1 |
| Aldandan, HW | 1 |
| Khandelwal, A | 1 |
| Kumar, N | 1 |
| Hawkes, MA | 1 |
| Hlavnicka, AA | 1 |
| Wainsztein, NA | 1 |
3 other studies available for milrinone and Cerebrovascular Disorders
| Article | Year |
|---|---|
Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
Topics: Adult; Cerebrovascular Disorders; Eclampsia; Female; Headache Disorders, Primary; Humans; Milrinone; | 2021 |
Reply to "Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone".
Topics: Administration, Intravenous; Cerebrovascular Disorders; Humans; Milrinone; Vasoconstriction; Vasospa | 2020 |
Reply to "Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone".
Topics: Administration, Intravenous; Cerebrovascular Disorders; Humans; Milrinone; Vasoconstriction; Vasospa | 2020 |